Yuri Maricich MD MBA

CMO at Pear Therapeutics. Physician #clindev #biotech #pharma #Investing, #Advising #HLS: #digitalhealth, #devices. #VC/#PE #digitaltherapeutics #healthdata

[Joe Doyle @JoeDoyleHealth]

⁦@FirstLadyND⁩ tells us her story about drinking, driving, DUIs, continued alcohol use and her path to 21 years #recovery and #sobriety. What a role model. I’m grateful to be in this session, given I’m at five years of alcohol free living as well. #sxsw23 #tackleaddiction

[Joe Doyle @JoeDoyleHealth]

Sitting in with @ymaricich, @FirstLadyND, @lipiroy and Dr. Wilson Compton of NIDA.

https://t.co/6DtTdOctSl

#SXSW23

[Pear Therapeutics @Pear_Tx]

Thank you @SenatorShaheen, @SenCapito, @MarshaBlackburn, @CoryBooker, @repkevinhern,
@RepThompson, @RepBillJohnson, and @DorisMatsui for your bipartisan support on this critical legislation.

[Pear Therapeutics @Pear_Tx]

Today, the bipartisan Access to Prescription Digital Therapeutics Act of 2023 (S. 723/ H.R. 1458) was reintroduced in Congress. If approved, this legislation could play a pivotal role in improving access to #PDTs. Learn more: https://t.co/UdMuIWzK1f

[Yuri Maricich MD MBA @ymaricich]

More news at Pear Therapeutics expanding access to patients:

#sud #oud #digitalhealth #pdt #dtx #biotech

https://t.co/EWr6v2Zmwq

[Yuri Maricich MD MBA @ymaricich]

Expanding care to more patients with California Department of Health Care Services, @Pear_Tx:

https://t.co/RjLv7TOGcR

#sud #digitalhealth #dtx #pdt #biotech #california

[Pear Therapeutics @Pear_Tx]

We're thrilled to kick off 2023 by growing our work with @SperoHealth1 to expand access to prescription digital therapeutics (#PDTs) for people living with substance use disorder (SUD) and opioid use disorder (OUD) in the US. Learn more about this collaboration.

[Yuri Maricich MD MBA @ymaricich]

More News @Pear_Tx

https://t.co/hJcCz4LCbn
#sud #oud #digitalhealth #dtx #pdt

[Yuri Maricich MD MBA @ymaricich]

Thanks @StevenChanMD for moderating an important discussion. Thank you @Ipsitv and team for all your work and focus on making #TIPS2022 and #technology in #Psychiatry a growing effort to make sure we learn as a profession how to deliver #evidence-based #softwaretreatments to pts

[Steven Chan, MD MBA @StevenChanMD]

It was wonderful to moderate at the @McLeanHospital #TIPS2022 Technology in #Psychiatry Summit, hearing about #digitalheath with Dr. Alavi (@alavi_nazanin) , Dr. Zucker Of @TwillHealth, Dr. Choudhary of @talkspace, Dr. Ong of @doxyme and Dr. Maricich of @Pear_Tx !

[Yuri Maricich MD MBA @ymaricich]

Pleased to share new, naturalistic #realworldevidence study on patients with #sud being treated with a #pdt #digitalhealth #biotech

[Pear Therapeutics @Pear_Tx]

New data in the American Journal on Addictions illustrates the potential of prescription digital therapeutics (#PDTs) for the treatment of substance use disorder (#SUD), a condition that more than 40 million Americans are living with. For more on the effectiveness of PDTs for SUD

[Yuri Maricich MD MBA @ymaricich]

More news from @Pear_Tx on interim real-world data from our DREAM study in patients with #chronicinsomnia #digitalhealth #dtx #pdts #biotech https://t.co/taNTlh4PT6

[Pear Therapeutics @Pear_Tx]

At #SLEEP2022, we presented real-world data from our prescription digital therapeutic for chronic insomnia and its potential impact on psychiatric co-morbidities. Find out more about this data:

[Yuri Maricich MD MBA @ymaricich]

Looking forward to participating in this event and the work of @amcporg and participating organization to improve access and value to underserved and minority populations to address Health Disparities… @Pear_Tx #healthequity #digitalhealth #pdts #biotech

[AMCP @amcporg]

This Thursday, join AMCP and other health care leaders to create actionable solutions to improve the value and access to life-saving medications and treatments for all Americans. Reserve your spot now for the AMCP Summit: Addressing Health Disparities: https://t.co/HSPz9TAUK8

[Yuri Maricich MD MBA @ymaricich]

Looking forward to participating in this event and the work of AMCP and participating organization to improve access and value to underserved and minority populations to address Health Disparities… #healthequity #digitalhealth #pdts #biotech

[Pear Therapeutics @Pear_Tx]

In the fight for #healthequity, we’re committed to reducing barriers to medication access and treatment. At the @AMCPorg Health Disparities Summit, our CMO @ymaricich, MD, MBA is discussing how we can bring key stakeholders together to optimize patient care.

[Yuri Maricich MD MBA @ymaricich]

Some @Pear_Tx #data presented at #apaam22: https://t.co/52OU0jpog5 #oud #dtx #pdts #biotech

[Pear Therapeutics @Pear_Tx]

More people than ever before are dying due to drug overdoses. As part of our efforts to fight the addiction epidemic, we’re pleased to work with @QuickMD_Telemed to provide additional telehealth care options to people with opioid use disorder (OUD). Learn more.

[Yuri Maricich MD MBA @ymaricich]

More news from @Pear_Tx: #pain #digitalhealth #dtx #pdt #biotech https://t.co/lzGyAuwLio

[Yuri Maricich MD MBA @ymaricich]

More news to support integration of #PDTs into clinical and technical workflow of clinicians and provider organizations:
#digitalhealth #dtx #Interoperability #epic #ehr

[Pear Therapeutics @Pear_Tx]

Our PearConnect platform is now available for healthcare providers in the Epic App Orchard Gallery. With this listing, Pear can provide seamless workflow integration for ease in managing patients who have been prescribed Pear's PDTs. Find out more:

[Yuri Maricich MD MBA @ymaricich]

Looking forward to sharing how health systems, IDNs, and risk-bearing organizations are improving access, increasing outcomes and aligning around value with software-based treatments.

[Pear Therapeutics @Pear_Tx]

For those attending #HIMSS22 next week, don’t miss hearing from our CCO Julia Strandberg and CMO @ymaricich on how prescription digital therapeutics (#PDTs) can deliver better outcomes for patients and cost-effective solutions for payers.

[Pear Therapeutics @Pear_Tx]

Patient-centricity is key to our work. Hear Rachid, a product manager at Pear, discuss how we develop new tools to treat serious diseases like addiction and chronic insomnia with the patient in mind. #LifeAtPear

[Pear Therapeutics @Pear_Tx]

Our prescription digital therapeutics for the treatment of substance and opioid use disorder are now available in Spanish. This initiative expands access to care and brings this innovative therapy to more patients in recovery.
https://t.co/IvcgOWRKYj